Ixense
·
- Prescription status not stated
- Urinary and reproductive system, hormones
- Active substance
- Apomorphine
- Made by
- Takeda Europe R Centre Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.In order for Ixense to be effective, sexual stimulation is required.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
BulgariaNo exact match for this strength and form
Details
| Made by | Takeda Europe R Centre Ltd. |
|---|---|
| Active substance | Apomorphine |
| Used in | Urinary and reproductive system, hormones |
| Classification | G04BE · Urinary and reproductive system, hormones |
| Authorised on | 2001-05-28 |
| Last updated by the regulator | 2004-11-10 |
| EMA product number | EMEA/H/C/000328 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.